The changing face of cardiovascular disease 2000–2012: An analysis of the world health organisation global health estimates data

CJ McAloon, LM Boylan, T Hamborg, N Stallard… - International journal of …, 2016 - Elsevier
The pattern and global burden of disease has evolved considerably over the last two
decades, from primarily communicable, maternal, and perinatal causes to non …

Cardiac dysrhythmias and thyroid dysfunction-The hidden menace?

F Osman, MD Gammage, MC Sheppard… - The Journal of …, 2002 - academic.oup.com
Thyrotoxicosis is often perceived as a reversible disorder without long-term consequences,
perhaps because of the availability of effective treatments, but recent evidence suggests that …

[HTML][HTML] Cardiovascular biomarkers: lessons of the past and prospects for the future

F Omran, I Kyrou, F Osman, VG Lim… - International Journal of …, 2022 - mdpi.com
Cardiovascular diseases (CVDs) are a major healthcare burden on the population
worldwide. Early detection of this disease is important in prevention and treatment to …

Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study

F Osman, JA Franklyn, RL Holder, MC Sheppard… - Journal of the American …, 2007 - jacc.org
Objectives: This study sought to prospectively evaluate the prevalence of cardiovascular
abnormalities in patients with overt hyperthyroidism before and after antithyroid therapy …

[HTML][HTML] COVID-19 and arrhythmia: An overview

JA Varney, VS Dong, T Tsao, MS Sabir, AT Rivera… - Journal of …, 2022 - Elsevier
Arrhythmias in COVID-19 patients are associated with hypoxia, myocardial ischemia,
cytokines, inflammation, electrolyte abnormalities, pro-arrhythmic or QT-prolonging …

Successful treatment of amiodarone-induced thyrotoxicosis

F Osman, JA Franklyn, MC Sheppard, MD Gammage - Circulation, 2002 - Am Heart Assoc
Background—Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem
about which there are little published data. We examined whether continuing amiodarone or …

Hyperthyroidism and cardiovascular morbidity and mortality

F Osman, MD Gammage, JA Franklyn - Thyroid, 2002 - liebertpub.com
Hyperthyroidism is a common disorder affecting multiple systems in the body. The
cardiovascular effects are among the most striking. The availability of effective treatments for …

High-intensity interval training in cardiac rehabilitation: a multi-centre randomized controlled trial

G McGregor, R Powell, B Begg… - European journal of …, 2023 - academic.oup.com
Background There is a lack of international consensus regarding the prescription of high-
intensity interval training (HIIT) for people with coronary artery disease (CAD) attending …

Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment

F Osman, JA Franklyn, J Daykin, S Chowdhary… - The American journal of …, 2004 - Elsevier
Patients with subclinical and treated overt hyperthyroidism have an excess vascular
mortality rate. Several symptoms and signs in overt hyperthyroidism suggest abnormality of …

Impact of sodium-glucose co-transporter inhibitors on cardiac autonomic function and mortality: no time to die

VG Lim, H He, T Lachlan, GA Ng, I Kyrou… - EP …, 2022 - academic.oup.com
Abstract Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been shown to improve
cardiovascular outcomes not only in patients with diabetes but also in those with heart …